- Home
- JANX vs CNXC Comparison
JANX vs CNXC Comparison
Compare JANX & CNXC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | JANX | CNXC |
|---|---|---|
| Founded | 2017 | 1991 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Computer Software: Prepackaged Software |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.8B | 2.6B |
| IPO Year | 2021 | N/A |
Fundamental Metrics
Financial Performance| Metric | JANX | CNXC |
|---|---|---|
| Price | $13.94 | $44.13 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 12 | 5 |
| Target Price | $60.27 | ★ $69.00 |
| AVG Volume (30 Days) | ★ 2.3M | 904.1K |
| Earning Date | 02-26-2026 | 01-13-2026 |
| Dividend Yield | N/A | ★ 3.36% |
| EPS Growth | N/A | ★ 54.10 |
| EPS | N/A | ★ 4.74 |
| Revenue | $10,000,000.00 | ★ $9,720,870,000.00 |
| Revenue This Year | N/A | $4.00 |
| Revenue Next Year | N/A | $3.16 |
| P/E Ratio | ★ N/A | $9.04 |
| Revenue Growth | N/A | ★ 3.40 |
| 52 Week Low | $13.26 | $31.63 |
| 52 Week High | $61.59 | $66.00 |
Technical Indicators
Market Signals| Indicator | JANX | CNXC |
|---|---|---|
| Relative Strength Index (RSI) | 32.06 | 67.06 |
| Support Level | $13.26 | $40.03 |
| Resistance Level | $14.30 | $42.63 |
| Average True Range (ATR) | 0.45 | 1.36 |
| MACD | 0.45 | 0.28 |
| Stochastic Oscillator | 61.29 | 89.68 |
Price Performance
Historical ComparisonAbout JANX Janux Therapeutics Inc.
Janux Therapeutics Inc is a clinical-stage biopharmaceutical company developing tumor-activated immunotherapies for cancer. Its proprietary technology has enabled the development of two distinct bispecific platforms: Tumor Activated T Cell Engagers (TRACTr) and Tumor Activated Immunomodulators (TRACIr). The TRACTr platform produces T cell engagers (TCEs) with a tumor antigen-binding domain and a CD3 T cell binding domain, while the TRACIr platform produces bispecifics with a tumor antigen-binding domain and a costimulatory CD28 binding domain.
About CNXC Concentrix Corporation
Concentrix Corp is a technology enabled company specialized in customer engagement and customer management. The company provides end-to-end capabilities, including CX process optimization, technology innovation and design engineering, front- and back-office automation, analytics and business transformation services to clients in five industry verticals. The Company's verticals are technology and consumer electronics, retail, travel and e-commerce, communications and media, banking, financial services and insurance, and healthcare. Geographically, the company operates in Philippines, Unites States, India, Frances and Others. Maximum revenue is from Technology and consumer electronics industry and geographically from Philippines.